NCT06767345View on ClinicalTrials.gov

Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

PHASE4RecruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

January 25, 2028

Study Completion Date

June 25, 2028

Conditions
Coronary Artery DiseaseAtherosclerosis of Coronary ArteryPlaque, Atherosclerotic
Interventions
DRUG

statins, ezetimibe

Rosuvastatin 20mg once daily

DRUG

Combination therapy

Rosuvastatin 10mg + Ezetimibe 10mg

Trial Locations (1)

02841

RECRUITING

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Yuhan Corporation

INDUSTRY

collaborator

Hanmi Pharmaceutical co., ltd.

OTHER

lead

Korea University Anam Hospital

OTHER

NCT06767345 - Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization | Biotech Hunter | Biotech Hunter